Role of metalloproteinases in rotator cuff tear

Sports Medicine and Arthroscopy Review

Volumn 19, Issue 3, 2011, Pages 207-212

  Garofalo, Raffaele ^a   Cesari, Eugenio ^b   Vinci, Enzo ^b   Castagna, Alessandro ^b  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

collagenases; extracellular matrix; metalloproteinases; rotator cuff tear; shoulder pain; zinc endopeptidases

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DOXYCYCLINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; TETRACYCLINE; TISSUE INHIBITOR OF METALLOPROTEINASE;

DRUG EFFICACY; DRUG MECHANISM; EXTRACELLULAR MATRIX; HEALING; HUMAN; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; ROTATOR CUFF RUPTURE; TENDON;

HUMANS; METALLOPROTEASES; ROTATOR CUFF; TENDON INJURIES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 80051723833     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0b013e318227b07b     Document Type: Review

References (66)

1. Goutallier D, Postel JM, Van Driessche S, et al. Histological lesions of supraspinatus tendons in full thickness tears of the rotator cuff. Rev Chir Orthop Reparatrice Appar Mot. 2005;91:109-113. (Pubitemid 40524932)
2. Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and remodelling. J Musculoskelet Neuronal Interact. 2006;6:181-190. (Pubitemid 44193219)
3. Sharma P, Maffulli N. Tendinopathy and tendon injury: the future. Disabil Rehabili. 2008;30:1733-1745.
4. Longo UG, Franceschi F, Ruzzini L, et al. Histopathology of the supraspinatus tendon in rotator cuff tears. Am J Sports Med. 2008;36:533-538. (Pubitemid 351253387)
5. Arnoczky SP, Lavagnino M, Egerbacher M, et al. Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study. Am J Sports Med. 2007;35:763-769. (Pubitemid 46956274)
6. Magra M, Maffulli N. Matrix metalloproteases: a role in overuse tendinopathies. Br J Sports Med. 2005;39:789-791. (Pubitemid 41564911)
7. Magra M, Maffulli N. Molecular events in tendinopathy: a role for metalloproteases. Foot Ankle Clin. 2005;10:267-277. (Pubitemid 40732786)
8. Longo UG, Oliva F, Denaro V, et al. Oxygen species and overuse tendinopathy in athletes. Disabil Rehabil. 2008;30:1563-1571.
9. Dalton S, Cawston TE, Riley GP, et al. Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis. 1995;54:571-577.
10. Gardner K, Arnoczky SP, Caballero O, et al. The effect of stress-deprivation and cyclic loading on the TIMP/MMP ratio in tendon cells: an in vitro experimental study. Disabil Rehabil. 2008;30:1523-1529.
11. Pasternak B, Aspenberg P. Metalloproteinases and their inhibitors": diagnostic and therapeutic opportunities in orthopedics. Acta Orthop. 2009;80(693-703):693.
12. Pearce WH, Shively VP. Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann N Y Acad Sci. 2006;1085:117-132. (Pubitemid 47091997)
13. Foos MJ, Hickox J, Mansour PG, et al. Expression of matrix metalloprotease and tissue inhibitor of metalloprotease genes in human anterior cruciate ligament. J Orthop Res. 2001;19:642-649. (Pubitemid 32700980)
14. Ren XH, Peng XD, Wu XP, et al. Association between serum soluble membrane type matrix metalloproteinase-1 (MT1-MMP) levels and bone mineral density, and biochemical markers in postmenopausal women. Clin Chim Acta. 2008;390:44-48.
15. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc. 2006;69:625-635. (Pubitemid 43139725)
16. Gabison E, Hoang-Xuan T. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005;87:361-368. (Pubitemid 40387615)
17. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93:178-193. (Pubitemid 32166488)
18. Chirco R, Liu XW, Jung KK, et al. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 2006;25:99-113. (Pubitemid 43723986)
19. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562-573. (Pubitemid 43139720)
20. Bramono DS, Richmond JC, Weitzel PP, et al. Matrix metalloproteinases and their clinical applications in orthopaedics. Clin Orthop. 2004;428:272-285. (Pubitemid 39506184)
21. Kuula H, Salo T, Pirila E, et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphymonas gingivalis-induced periodontitis. Infect Immun. 2009;77:850-859.
22. Gueders MM, Balbin M, Rocks N, et al. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol. 2005;175:2589-2597. (Pubitemid 41113872)
23. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007;98:621-628. (Pubitemid 46563436)
24. Jones GC, Riley GP. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther. 2005;7:160-169. (Pubitemid 40936607)
25. Karousou E, Ronga M, Vigetti D, et al. Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clin Orthop Relat Res. 2008;466:1577-1582.
26. Bedi A, Kovacevic D, Hettrich C, et al. The effect of matrix metalloproteinase inhibition on tendon-to-bone healing in a rotator cuff repair model.. J Shoulder Elbow Surg. 2009. [Sep. 30. Epub ahead of print].
27. Bedi A, Fox AJ, Kovacevic D, et al. Doxycycline-mediated inhibition of matrix metalloproteinases improves healing after rotator cuff repair. Am J Sports Med. 2009. Oct. 13. [Epub ahead of print].
28. Lee CZ, Xu B, Hashimoto T, et al. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke. 2004;35:1715-1719. (Pubitemid 38823653)
29. Peterson JT. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev. 2004;9:63-79. (Pubitemid 38202142)
30. O'Dell J, Elliott J, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis. 2006;54:621-627. (Pubitemid 43228640)
31. Walker C, Preshaw PM, Novak J, et al. Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. J Clin Periodontol. 2005;32:1163-1169. (Pubitemid 41499474)
32. Hu J, Van den Steen PE, Sang QX, et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007;6:480-498. (Pubitemid 47064570)
33. Heikkila P, Teronen O, Moilanen M, et al. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs. 2002;13:245-254. (Pubitemid 34492706)
34. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology. 2004;43:131-142. (Pubitemid 38219665)
35. De Mos M, van El B, DeGroot J, et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med. 2007;35:1549-1556. (Pubitemid 47301088)
36. Pasternak B, Rehn M, Andersen L, et al. P. Doxycyclinecoated sutures improve mechanical strength of intestinal anastomoses. Int J Colorectal Dis. 2008;23:271-276.
37. Raleigh SM, Van der Merwe L, Ribbans WJ, et al. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med. 2009;43:514-520.
38. Corps AN, Robinson AH, Movin T, et al. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology. 2006;45:291-294. (Pubitemid 43372843)
39. Orchard J, Massey A, Brown R, et al. Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin. Clin Orthop. 2008;466:1625-1632.
40. Brown R, Orchard J, Kinchington M, et al. Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial. Br J Sports Med. 2006;40:275-279. (Pubitemid 43384753)
41. Alfredson H. The chronic painful Achilles and patellar tendon: research on basic biology and treatment. Scand J Med Sci Sports. 2005;15:252-259. (Pubitemid 41032389)
42. Cury PR, Canavez F, de Araujo VC, et al. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts. J Periodontal Res. 2008;43:255-260.
43. Steyaert AE, Burssens PJ, Vercruysse CW, et al. The effects of substance P on the biomechanic properties of ruptured rat Achilles' tendon. Arch Phys Med Rehabil. 2006;87:254-258. (Pubitemid 43151302)
44. Franceschi F, Longo UG, Ruzzini L, et al. Circulating substance P levels and shoulder joint contracture after arthroscopic repair of the rotator cuff. Br J Sports Med. 2008;42:742-745.
45. Lo IK, Marchuk LL, Hollinshead R, et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med. 2004;32:1223-1229. (Pubitemid 38970376)
46. Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med. 2009;37:1855-1867.
47. Thornton GM, Shao X, Chung M, et al. Changes in mechanical loading lead to tendon-specific alterations in MMP and TIMP expression: Influence of stress-deprivation and intermittent cyclic hydrostatic compression on rat supraspinatus and Achilles tendons. Br J Sports Med. 2008;18. [Epub ahead of print].
48. Choi HR, Kondo S, Hirose K, et al. Expression and enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in rabbits. J Orthop Res. 2002;20:927-933.
49. Wang F, Murrell GA, Wang MX. Oxidative stress-induced c-Jun. N-terminal kinase (JNK) activation in tendon cells upregulates MMP1 mRNA and protein expression. J Orthop Res. 2007;25:378-389. (Pubitemid 46455908)
50. Tajana MS, Murena L, Valli F, et al. Correlations between biochemical markers in the synovial fluid and severity of rotator cuff disease. Musculoskelet surg with Chir Organi Mov. 2009;93(Suppl 1):41-48.
51. Blaine TA, Kim YS, Voloshin I, et al. The molecular pathophysiology of subacromial bursitis in rotator cuff disease. J Shoulder Elbow Surg. 2005;14(1 Suppl):84-89.
52. Voloshin I, Gelinas J, Maloney MD, et al. Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy. 2005;21:e1-e9.
53. Gotoh M, Hamada K, Yamakawa H, et al. Significance of granulation tissue in torn supraspinatus insertions: an immunohistochemical study with antibodies against interleukin-1 beta, cathepsin D, and matrix metalloprotease-1. J Orthop Res. 1997;15:33-39. (Pubitemid 27111198)
54. Tillander B, Franzen L, Fibronectin Norlin R. MMP-1 and histologic changes in rotator cuff disease. J Orthop Res. 2002;20:1358-1364. (Pubitemid 35363998)
55. Joseph M, Maresh CM, McCarthy MB, et al. Histological and molecular analysis of the biceps tendon long head posttenotomy. J Orthop Res. 2009;27:1379-1385.
56. Oshiro W, Lou J, Xing X, et al. Flexor tendon healing in the rat: a histologic and gene expression study. J Hand Surg Am. 2003;28:814-823. (Pubitemid 37175365)
57. Eliasson P, Fahlgren A, Aspenberg P. Mechanical load and BMP signaling during tendon repair: a role for follistatin? Clin Orthop. 2008;466:1592-1597.
58. Pasternak B, Fellenius M, Aspenberg P. Doxycycline impairs tendon repair in rats. Acta Orthop Belg. 2006;72:756-760. (Pubitemid 46048243)
59. Demirag B, Sarisozen B, Ozer O, et al. Enhancement of tendon-bone healing of anterior cruciate ligament grafts by blockage of matrix metalloproteinases. J Bone Joint Surg Am. 2005;87:2401-2410. (Pubitemid 41546369)
60. Yildirim Y, Kara H, Cabukoglu C, et al. Suture holding capacity of the Achilles tendon during the healing period: an in vivo experimental study in rabbits. Foot Ankle Int. 2006;27:121-124. (Pubitemid 43208644)
61. McDowell CL, Marqueen TJ, Yager D, et al. Characterization of the tensile properties and histologic/biochemical changes in normal chicken tendon at the site of suture insertion. J Hand Surg (Am). 2002;27:605-614. (Pubitemid 34779235)
62. Pasternak B, Missios A, Askendal A, et al. Doxycycline-coated sutures improve the suture-holding capacity of the rat Achilles tendon. Acta Orthop. 2007;78:680-686. (Pubitemid 350034946)
63. Gulotta LV, Kovacevic D, Montgomery S, et al. Stem cells genetically modified with the developmental gene MT1-MMP improve regeneration of the supraspinatus tendon-to-bone insertion site. Am J Sports Med. 2010;38:1429-1437.
64. Molloy TJ, de Bock CE, Wang Y, et al. Gene expression changes in SNAP-stimulated and iNOS-transfected tenocytes: expression of extracellular matrix genes and its implications for tendon-healing. J Orthop Res. 2006;24:1869-1882. (Pubitemid 44430422)
65. Triantafillopoulos IK, Banes AJ, Bowman KF Jr, et al. Nandrolone decanoate and load increase remodeling and strength in human supraspinatus bioartificial tendons. Am J Sports Med. 2004;32:934-940.
66. Tempfer H, Gehwolf R, Lehner C, et al. Effects of crystalline glucocorticoid triamcinolone acetonide on cultured human supraspinatus tendon cells. Acta Orthop. 2009;80:357-362.